Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.
Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A, Fischer M, Frühwald M, Henze G, Klingebiel T, Kratz C, Kremens B, Krug B, Leuschner I, Schmidt M, Schmidt R, Schumacher-Kuckelkorn R, von Schweinitz D, Schilling FH, Theissen J, Volland R, Hero B, Simon T.
Berthold F, et al. Among authors: von schweinitz d.
Ann Oncol. 2020 Mar;31(3):422-429. doi: 10.1016/j.annonc.2019.11.011. Epub 2020 Jan 24.
Ann Oncol. 2020.
PMID: 32067684
Free article.
Clinical Trial.